Neuropsychiatric Drug Developers Show a Renewed Sense of Purpose
Therapeutics for depression, schizophrenia, and other neuropsychiatric disorders are targeting inflammation, stimulating neurogenesis, and taking cues from biomarkers.
Source: genengnews.com